Pseudobulbar affect, or PBA, is a neurological condition that causes sudden, uncontrollable episodes of crying or laughing that don’t match how you actually feel. You might burst into tears during a casual conversation or laugh uncontrollably at a funeral, not because of your emotions but because the brain’s ability to regulate emotional expression has been disrupted. PBA affects millions of people with underlying neurological conditions, yet it’s frequently misdiagnosed as depression or a psychiatric disorder.
How PBA Differs From a Mood Disorder
The hallmark of PBA is a disconnect between what you feel inside and what your face and voice express. With depression, crying is tied to your mood: it starts when you feel sad and stops when the sadness lifts. PBA episodes are different in three key ways. They’re uncontrollable, meaning you can’t stop them through willpower. They arrive suddenly and without a predictable trigger, lasting seconds to minutes rather than the sustained tearfulness of a depressive episode. And they’re usually incongruent with your actual mood, so you may find yourself sobbing while feeling perfectly fine, or laughing in a serious or somber moment.
This mismatch is what makes PBA so distressing. People around you interpret the outburst as a genuine emotional reaction, which leads to confusion and misunderstanding. Depression and PBA can coexist in the same person, which further complicates the picture, but they are fundamentally different problems. Depression is a mood disorder. PBA is a problem with the brain’s wiring for emotional expression.
What Happens in the Brain
The exact cause isn’t fully understood, but PBA appears to result from disruption along a specific brain pathway that connects the cerebral cortex to the cerebellum through the brainstem. Your cerebellum, better known for coordinating movement, also plays a key role in monitoring emotional responses and making sure they’re appropriate for the social situation. When neurological damage interrupts the signals traveling from higher brain regions to the cerebellum, the result is a loss of the “gate” that normally keeps emotional expression in check. Your brain essentially loses its ability to match the intensity and type of outward expression to what you’re actually feeling.
Neurological Conditions That Cause PBA
PBA doesn’t appear on its own. It develops as a consequence of damage or disease affecting the brain. The rates are strikingly high across several common neurological conditions. In surveys using a validated screening tool, about 48% of people with multiple sclerosis, 53% of stroke survivors, and 80% of people with traumatic brain injury scored above the threshold for clinically significant PBA. Among people with Parkinson’s disease, estimates range from about 4% to 43%, a wide spread that reflects differences in how studies define and measure it. ALS (amyotrophic lateral sclerosis) is another well-known trigger, with roughly 28% of patients meeting the diagnostic cutoff in one large study of over 700 people.
PBA can also appear in people with Alzheimer’s disease and other dementias, as well as certain brain tumors. Any condition that damages the pathways connecting the cortex, brainstem, and cerebellum can potentially cause it.
How PBA Is Identified
There’s no blood test or brain scan for PBA. Diagnosis relies on recognizing the pattern of symptoms, particularly episodes that are involuntary, exaggerated relative to the situation, and out of proportion to or disconnected from the person’s underlying mood. The most widely used screening tool is the Center for Neurologic Study-Lability Scale (CNS-LS), a seven-item questionnaire that asks about the frequency and controllability of laughing and crying episodes. Scores range from 7 to 35, with a score of 13 or higher indicating clinically significant PBA. In ALS populations, that threshold has a sensitivity of 84% and specificity of 81%, meaning it catches most true cases while correctly ruling out most people who don’t have it.
One of the biggest barriers to diagnosis is that clinicians often attribute the crying to depression or assume the emotional outbursts are a natural response to living with a serious illness. PBA is notoriously underrecognized, which means many people go without appropriate treatment for months or years.
The Social and Emotional Toll
Living with PBA creates a layer of suffering that sits on top of whatever neurological condition caused it. The episodes are embarrassing and unpredictable. Many people begin avoiding social situations altogether, declining invitations, skipping family events, and pulling away from friends, because they can’t predict when an outburst will happen. This social withdrawal deepens isolation at a time when connection matters most.
Research consistently shows that PBA has a significant impact on quality of life for both patients and their families. In one study of people with a progressive neurological condition, the impact scores for PBA ranged widely, but crying episodes were most strongly linked to functional and social burden. Caregivers and loved ones often struggle too, unsure whether the person is genuinely distressed or experiencing an involuntary episode. The resulting confusion can strain relationships and make everyday interactions feel fraught.
Treatment Options
The only medication specifically approved by the FDA for PBA is a combination of dextromethorphan and quinidine. Dextromethorphan, the active ingredient in many cough suppressants, acts on brain receptors involved in emotional regulation, though the precise way it reduces PBA episodes isn’t fully understood. The quinidine component doesn’t treat PBA directly. Instead, it slows the body’s breakdown of dextromethorphan so enough of the drug reaches the brain. Treatment typically starts with one dose daily for the first week, then increases to twice daily.
Before this combination was approved, doctors relied entirely on antidepressants prescribed off-label, and many still do. SSRIs and tricyclic antidepressants have both shown effectiveness in reducing the frequency and severity of PBA episodes in small clinical trials. The doses used are generally at the lower end of what’s prescribed for depression, suggesting PBA and depression may respond through different mechanisms even when the same medication is used. Multiple small trials of SSRIs across stroke, MS, TBI, and ALS populations reported reduced episode rates and severity, though many of these studies were uncontrolled or used measures that hadn’t been formally validated.
Managing Episodes Day to Day
Beyond medication, many people develop personal strategies for getting through episodes. Slow, deliberate breathing during an episode can sometimes shorten its duration. Changing your body position, such as relaxing your shoulders or unclenching your jaw, may help interrupt the physical pattern of crying or laughing. Some people find that shifting their attention to a specific mental task, like counting backward or focusing on an object in the room, gives the episode a chance to pass more quickly.
Perhaps the most useful practical step is simply telling the people in your life what PBA is. When family, friends, and coworkers understand that the outbursts aren’t a reflection of your emotional state, the pressure of each episode drops considerably. You no longer have to explain or apologize in the moment, and the people around you can respond with patience rather than alarm. That shift alone can make PBA significantly more manageable, even before medication enters the picture.